Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NTRK3 antisense RNA 1 (NTRK3-AS1)
- Target
- NTRK3-AS1
- Molecular classification
- Long non-coding RNA (lncRNA), antisense RNA
01
Overview
NTRK3 antisense RNA 1 (NTRK3-AS1) is a long non-coding RNA transcribed antisense to the NTRK3 gene, classified under the sequence ontology as an antisense_lncRNA_gene. It comprises at least two annotated transcripts, varying in length (2663 bp and 605 bp)[3]. There is currently no direct functional or disease association reported for NTRK3-AS1 in curated literature databases, and no information about its role as a therapeutic target, biomarker, or drug interactor. Antisense lncRNAs like NTRK3-AS1 are generally implicated in the regulation of their sense gene counterparts, but for NTRK3-AS1, direct biological roles remain undefined in published scientific sources as of this analysis[3]. Important distinction: NTRK3-AS1 is *not* the protein-coding NTRK3 receptor (neurotrophin receptor tyrosine kinase 3), which has established roles in neurobiology and cancer[1]. NTRK3-AS1 is a distinct, non-coding RNA associated with, but separate from, the NTRK3 gene and its protein product.
- Other names
- NTRK3 antisense RNA 1 (non-protein coding)NTRK3-AS1
02
Biological functions
Unknown (no definitive biological function established in public sources; generally, antisense lncRNAs are involved in transcriptional regulation or RNA stability)
03
Disease associations
Unknown (no linked literature or clear evidence for roles in diseases such as cancer or other conditions found in reviewed sources[3])
Beyond the preview
Go deeper on NTRK3 antisense RNA 1 (NTRK3-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NTRK3 antisense RNA 1 (NTRK3-AS1).